Graph Therapeutics, a next-generation techbio company developing precision medicinesfor inflammatory and immune-mediated diseases, has secured a new $5 millioninvestment led by Daphni, the Paris-based…
MIT Technology Review Explains: Let our writers untangle the complex, messy world of science and technology to help you understand what’s coming next. You can read more from the series here. Your brain lives in the dark space of your skull. Yet it knows when the wind lifts the hairs on your skin, when your heart is…
Apoha, a deeptech company pioneering what it calls Liquid State Intelligence emerges from stealth today with $36 million in funding. The round is led by Singular, with participation from Tim Draper’s…
Deep Science Ventures (DSV), a UK-based deeptech venture creator, and Medicines Discovery Catapult (MDC), a life sciences service dedicated to turning drug discovery into commercial breakthroughs, tod…
Swiss biotech startup hephaistos.bio hassecured €161,000 (CHF 150,000) from Venture Kick to accelerate the developmentof custom enzyme solutions for pharmaceutical and chemical manufacturing.Chemical …
The Enhanced Games — a singular sporting competition where a majority of the athletes were on performance enhancing drugs — may herald a new business model that the tech industry is ready to embrace.
UK biotech iFAST Diagnostics has closed a £5 million funding round. iFAST is addressing the $4 billion (and growing) Antimicrobial Susceptibility Testing (AST) market. It has developed a test deliveri…
Mykor, a UK biotechnology companydeveloping low-carbon construction materials from industrial and agriculturalwaste, has secured £4 million in funding to accelerate the scale-up of itsindustrial biofa…
PacificoBiolabs, a mycelium fermentation protein company, has raised €7 million in aSeries A funding round backed by Stray Dog Capital, TGFS, Sprout & AboutVentures, Simon Capital, FoodLabs, and a…